195 related articles for article (PubMed ID: 34922941)
1. Bifidobacterium longum subsp. longum 5
Quintanilha MF; Miranda VC; Souza RO; Gallotti B; Cruz C; Santos EA; Alvarez-Leite JI; Jesus LCL; Azevedo V; Trindade LM; Cardoso VN; Ferreira E; Carvalho BA; Soares PMG; Vieira AT; Nicoli JR; Martins FS
Life Sci; 2022 Jan; 289():120243. PubMed ID: 34922941
[TBL] [Abstract][Full Text] [Related]
2. Preventative effects of selenium-enriched
Qiu Y; Zhang J; Ji R; Zhou Y; Shao L; Chen D; Tan J
Benef Microbes; 2019 May; 10(5):569-577. PubMed ID: 30964326
[TBL] [Abstract][Full Text] [Related]
3. Selenium-enriched Bifidobacterium longum DD98 attenuates irinotecan-induced intestinal and hepatic toxicity in vitro and in vivo.
Zhu H; Lu C; Gao F; Qian Z; Yin Y; Kan S; Chen D
Biomed Pharmacother; 2021 Nov; 143():112192. PubMed ID: 34649340
[TBL] [Abstract][Full Text] [Related]
4. Paraprobiotic Enterococcus faecalis EC-12 prevents the development of irinotecan-induced intestinal mucositis in mice.
Nobre LMS; da Silva Lopes MH; Geraix J; Cajado AG; Silva JMR; Ribeiro LR; Freire RS; Cavalcante DIM; Wong DVT; Alves APNN; Lima-Júnior RCP
Life Sci; 2022 May; 296():120445. PubMed ID: 35245522
[TBL] [Abstract][Full Text] [Related]
5. Bifidobacterium longum subsp. longum 5
Santos SS; Miranda VC; Trindade LM; Cardoso VN; Reis DC; Cassali GD; Nicoli JR; Cara DC; Martins FS
Probiotics Antimicrob Proteins; 2023 Feb; 15(1):63-73. PubMed ID: 34558015
[TBL] [Abstract][Full Text] [Related]
6. Treatment with
Abrantes FA; Nascimento BB; Andrade MER; de Barros PAV; Cartelle CT; Martins FS; Nicoli JR; Arantes RME; Generoso SV; Fernandes SOA; Cardoso VN
Benef Microbes; 2020 Feb; 11(1):47-57. PubMed ID: 32066260
[TBL] [Abstract][Full Text] [Related]
7. Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses.
Kato S; Hamouda N; Kano Y; Oikawa Y; Tanaka Y; Matsumoto K; Amagase K; Shimakawa M
Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1017-1025. PubMed ID: 28590519
[TBL] [Abstract][Full Text] [Related]
8. Bifidobacterium longum SX-1326 ameliorates gastrointestinal toxicity after irinotecan chemotherapy via modulating the P53 signaling pathway and brain-gut axis.
Yue F; Zeng X; Wang Y; Fang Y; Yue M; Zhao X; Zhu R; Zeng Q; Wei J; Chen T
BMC Microbiol; 2024 Jan; 24(1):8. PubMed ID: 38172689
[TBL] [Abstract][Full Text] [Related]
9. Preventive oral supplementation with
Ribeiro WR; Queiroz AG; Mendes E; Casaro MB; Nascimento CM; Coelho LSSF; Martins FS; Leite-Silva VR; Ferreira CM
Benef Microbes; 2021 Apr; 12(2):199-209. PubMed ID: 33573507
[TBL] [Abstract][Full Text] [Related]
10.
Tang J; Zhao M; Miao X; Chen H; Zhao B; Wang Y; Guo Y; Wang T; Cheng X; Ruan H; Zhang J
Food Funct; 2024 Apr; 15(7):3653-3668. PubMed ID: 38487897
[TBL] [Abstract][Full Text] [Related]
11. Modulations of probiotics on gut microbiota in a 5-fluorouracil-induced mouse model of mucositis.
Yeung CY; Chiang Chiau JS; Cheng ML; Chan WT; Chang SW; Chang YH; Jiang CB; Lee HC
J Gastroenterol Hepatol; 2020 May; 35(5):806-814. PubMed ID: 31674687
[TBL] [Abstract][Full Text] [Related]
12. Dihydrotanshinone attenuates chemotherapy-induced intestinal mucositis and alters fecal microbiota in mice.
Wang L; Wang R; Wei GY; Wang SM; Du GH
Biomed Pharmacother; 2020 Aug; 128():110262. PubMed ID: 32447214
[TBL] [Abstract][Full Text] [Related]
13. Supplementation with Bifidobacterium longum Bar33 and Lactobacillus helveticus Bar13 mixture improves immunity in elderly humans (over 75 years) and aged mice.
Finamore A; Roselli M; Donini L; Brasili DE; Rami R; Carnevali P; Mistura L; Pinto A; Giusti A; Mengheri E
Nutrition; 2019; 63-64():184-192. PubMed ID: 31029046
[TBL] [Abstract][Full Text] [Related]
14. Probiotic effect of Bifidobacterium longum 5
Fonseca JF; Alvim LB; Nunes ÁC; Oliveira FMS; Amaral RS; Caliari MV; Nicoli JR; Neumann E; Gomes MA
J Appl Microbiol; 2019 Oct; 127(4):1184-1191. PubMed ID: 31155822
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice.
Matsumoto T; Ishikawa H; Tateda K; Yaeshima T; Ishibashi N; Yamaguchi K
J Appl Microbiol; 2008 Mar; 104(3):672-80. PubMed ID: 17927741
[TBL] [Abstract][Full Text] [Related]
16. Paraprobiotic Lacticaseibacillus rhamnosus Protects Intestinal Damage in an Experimental Murine Model of Mucositis.
Trindade LM; Torres L; Matos ID; Miranda VC; de Jesus LCL; Cavalcante G; de Souza Oliveira JJ; Cassali GD; Mancha-Agresti P; de Carvalho Azevedo VA; Maioli TU; Cardoso VN; Martins FDS; de Vasconcelos Generoso S
Probiotics Antimicrob Proteins; 2023 Apr; 15(2):338-350. PubMed ID: 34524605
[TBL] [Abstract][Full Text] [Related]
17. Probiotic
Budden KF; Gellatly SL; Vaughan A; Amorim N; Horvat JC; Hansbro NG; Wood DLA; Hugenholtz P; Dennis PG; Wark PAB; Hansbro PM
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613693
[No Abstract] [Full Text] [Related]
18. Probiotic mixture containing
Quaresma M; Damasceno S; Monteiro C; Lima F; Mendes T; Lima M; Justino P; Barbosa A; Souza M; Souza E; Soares P
Nutr Cancer; 2020; 72(8):1355-1365. PubMed ID: 31608714
[No Abstract] [Full Text] [Related]
19. The administration of Escherichia coli Nissle 1917 ameliorates irinotecan-induced intestinal barrier dysfunction and gut microbial dysbiosis in mice.
Wang Y; Sun L; Chen S; Guo S; Yue T; Hou Q; Feng M; Xu H; Liu Y; Wang P; Pan Y
Life Sci; 2019 Aug; 231():116529. PubMed ID: 31173781
[TBL] [Abstract][Full Text] [Related]
20. A ropy exopolysaccharide producing strain Bifidobacterium longum subsp. longum YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation.
Yan S; Yang B; Zhao J; Zhao J; Stanton C; Ross RP; Zhang H; Chen W
Food Funct; 2019 Mar; 10(3):1595-1608. PubMed ID: 30806428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
